Deborah L. Birx
About
Deborah L. Birx is a scholar working on Virology, Infectious Diseases and Immunology.
According to data from OpenAlex, Deborah L. Birx has authored 163 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 125 papers in Virology, 89 papers in Infectious Diseases and 47 papers in Immunology. Recurrent topics in Deborah L. Birx's work include HIV Research and Treatment (123 papers), HIV/AIDS Research and Interventions (57 papers) and HIV/AIDS drug development and treatment (49 papers). Deborah L. Birx is often cited by papers focused on HIV Research and Treatment (123 papers), HIV/AIDS Research and Interventions (57 papers) and HIV/AIDS drug development and treatment (49 papers). Deborah L. Birx collaborates with scholars based in United States, Thailand and Germany. Deborah L. Birx's co-authors include John R. Mascola, Francine E. McCutchan, Merlin L. Robb, Thomas C. VanCott, Sarah S. Frankel, Robert R. Redfield, Jean K. Carr, Mark G. Lewis, Hermann Katinger and Gabriela Stiegler and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.
In The Last Decade
Deborah L. Birx
163 papers receiving 9.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Deborah L. Birx United States | 51 | 6.2k | 4.8k | 3.5k | 2.2k | 1.7k | 163 | 10.2k | ||
| Mark G. Lewis United States | 50 | 5.2k 0.8× | 3.4k 0.7× | 4.1k 1.2× | 2.5k 1.1× | 1.1k 0.7× | 193 | 9.2k | ||
| Preston A. Marx United States | 61 | 9.9k 1.6× | 4.7k 1.0× | 5.7k 1.7× | 4.9k 2.2× | 863 0.5× | 236 | 13.8k | ||
| Jan Albert Sweden | 62 | 9.5k 1.5× | 7.7k 1.6× | 2.7k 0.8× | 3.2k 1.4× | 577 0.3× | 274 | 13.0k | ||
| Feng Gao China | 54 | 8.2k 1.3× | 5.7k 1.2× | 3.3k 1.0× | 3.3k 1.5× | 645 0.4× | 246 | 12.4k | ||
| Mark B. Feinberg United States | 53 | 7.3k 1.2× | 3.9k 0.8× | 6.4k 1.8× | 2.9k 1.3× | 627 0.4× | 107 | 12.2k | ||
| Mark J. Mulligan United States | 46 | 2.4k 0.4× | 3.6k 0.7× | 3.2k 0.9× | 3.2k 1.4× | 1.5k 0.8× | 150 | 8.5k | ||
| Francis A. Plummer Canada | 62 | 5.0k 0.8× | 5.1k 1.1× | 3.7k 1.1× | 4.0k 1.8× | 963 0.6× | 283 | 13.1k | ||
| Luc Perrin Switzerland | 55 | 4.8k 0.8× | 4.1k 0.9× | 2.6k 0.7× | 2.4k 1.1× | 1.4k 0.8× | 160 | 9.1k | ||
| Stuart C. Ray United States | 51 | 3.8k 0.6× | 5.1k 1.0× | 2.4k 0.7× | 5.5k 2.5× | 640 0.4× | 152 | 13.7k | ||
| Hanneke Schuitemaker Netherlands | 63 | 10.6k 1.7× | 6.9k 1.4× | 5.8k 1.7× | 2.8k 1.2× | 533 0.3× | 273 | 13.4k |
Countries citing papers authored by Deborah L. Birx
Since
Specialization
Citations
This map shows the geographic impact of Deborah L. Birx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah L. Birx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah L. Birx more than expected).
Fields of papers citing papers by Deborah L. Birx
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Deborah L. Birx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah L. Birx. The network helps show where Deborah L. Birx may publish in the future.
Co-authorship network of co-authors of Deborah L. Birx
This figure shows the co-authorship network connecting the top 25 collaborators of Deborah L. Birx. A scholar is included among the top collaborators of Deborah L. Birx based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah L. Birx. Deborah L. Birx is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Lawrence, Patricia, et al.. (2024). The effects of a novel, continuous disinfectant technology on methicillin-resistant Staphylococcus aureus (MRSA), fungi, and aerobic bacteria in 2 separate intensive care units in 2 different states: An experimental design with observed impact on health care associated infections (HAIs). American Journal of Infection Control. 52(8). 884–892.
2.
Arroyo, Miguel A., Christian T. Bautista, Ginamarie Foglia, et al.. (2009). Short Communication: HIV Type 1 Genetic Diversity among Tea Plantation Workers in Kericho, Kenya. AIDS Research and Human Retroviruses. 25(11). 1061–1064.
3.
Tovanabutra, Sodsai, Gustavo H. Kijak, Chris Beyrer, et al.. (2007). Identification of CRF34_01B, a Second Circulating Recombinant Form Unrelated to and More Complex Than CRF15_01B, among Injecting Drug Users in Northern Thailand. AIDS Research and Human Retroviruses. 23(6). 829–833.
4.
LeBreton, Matthew, Otto O. Yang, Ubald Tamoufé, et al.. (2007). Exposure to Wild Primates among HIV-infected Persons. Emerging infectious diseases. 13(10). 1579–1582.
5.
Watanaveeradej, Veerachai, Michael W. Benenson, Mark de Souza, et al.. (2006). Molecular Epidemiology of HIV Type 1 in Preparation for a Phase III Prime-Boost Vaccine Trial in Thailand and a New Approach to HIV Type 1 Genotyping. AIDS Research and Human Retroviruses. 22(8). 801–807.
6.
Currier, Jeffrey R., Matthew E. Harris, Josephine H. Cox, et al.. (2005). Immunodominance and Cross-Reactivity of B5703-Restricted CD8 T Lymphocytes from HIV Type 1 Subtype C-Infected Ethiopians. AIDS Research and Human Retroviruses. 21(3). 239–245.
7.
Tovanabutra, Sodsai, Stephanie K. Brodine, John R. Mascola, et al.. (2005). Characterization of Complete HIV Type 1 Genomes from Non-B Subtype Infections in U.S. Military Personnel. AIDS Research and Human Retroviruses. 21(5). 424–429.
8.
Tovanabutra, Sodsai, Chris Beyrer, Supachai Sakkhachornphop, et al.. (2004). The Changing Molecular Epidemiology of HIV Type 1 among Northern Thai Drug Users, 1999 to 2002. AIDS Research and Human Retroviruses. 20(5). 465–475.
9.
Kijak, Gustavo H., Eric Sanders‐Buell, Nathan Wolfe, et al.. (2004). Development and Application of a High-Throughput HIV Type 1 Genotyping Assay to Identify CRF02_AG in West/West Central Africa. AIDS Research and Human Retroviruses. 20(5). 521–530.
10.
Kim, Jérôme H., Punnee Pitisuttithum, Thippawan Chuenchitra, et al.. (2003). Specific Antibody Responses to Vaccination with Bivalent CM235/SF2 gp120: Detection of Homologous and Heterologous Neutralizing Antibody to Subtype E (CRF01.AE) HIV Type 1. AIDS Research and Human Retroviruses. 19(9). 807–816.
11.
Chuenchitra, Thippawan, Chantapong Wasi, Sorachai Nitayaphan, et al.. (2003). Longitudinal Study of Humoral Immune Responses in HIV Type 1 Subtype CRF01_AE (E)-Infected Thai Patients with Different Rates of Disease Progression. AIDS Research and Human Retroviruses. 19(4). 293–305.
12.
Tasker, Sybil, Gail D. Chapman, A.H. Fagbami, et al.. (2002). HIV Type 1 Strains from East and West Africa Are Intermixed in Sudan. AIDS Research and Human Retroviruses. 18(15). 1163–1166.
13.
Souza, Mark de, Rapee Trichavaroj, Jean K. Carr, et al.. (2002). Heterosexually Acquired CRF01_AE/B Recombinant HIV Type 1 Found in Thailand. AIDS Research and Human Retroviruses. 18(16). 1235–1237.
14.
Polonis, Victoria R., Mark de Souza, Penprapa Chanbancherd, et al.. (2001). HIV Type 1 Subtype E-Infected Patients with Broadened, Dual (B/E) V3 Loop Serology Have Increased Cross-Neutralizing Antibodies. AIDS Research and Human Retroviruses. 17(1). 69–79.
15.
Souza, Mark de, Rapee Trichavaroj, Somchai Sriplienchan, et al.. (2001). Detection and Quantification of HIV Type 1 RNA in Nasopharyngeal Washes from HIV-Infected Subjects. AIDS Research and Human Retroviruses. 17(3). 229–232.
16.
Hioe, Catarina E., Gareth J. Jones, A. D. M. Rees, et al.. (2000). Anti-CD4-Binding Domain Antibodies Complexed with HIV Type 1 Glycoprotein 120 Inhibit CD4 + T Cell-Proliferative Responses to Glycoprotein 120. AIDS Research and Human Retroviruses. 16(9). 893–905.
17.
Schwartz, David H., Usha Sharma, Michael Busch, et al.. (1994). Absence of Recoverable Infectious Virus and Unique Immune Responses in an Asymptomatic HIV + Long-Term Survivor. AIDS Research and Human Retroviruses. 10(12). 1703–1711.
18.
Birx, Deborah L., et al.. (1994). Assessment of gag DNA and Genomic RNA in Peripheral Blood Mononuclear Cells in HIV-Infected Patients Receiving Intervention with a Recombinant gp160 Subunit Vaccine in a Phase I Study. AIDS Research and Human Retroviruses. 10(6). 649–654.
19.
Birx, Deborah L., Mark G. Lewis, Peter B. Jahrling, et al.. (1993). Association of Interleukin-6 in the Pathogenesis of Acutely Fatal SIV smm/PBj-14 in Pigtailed Macaques*. AIDS Research and Human Retroviruses. 9(11). 1123–1129.
20.
Redfield, Robert R. & Deborah L. Birx. (1992). HIV-Specific Vaccine Therapy: Concepts, Status, and Future Directions. AIDS Research and Human Retroviruses. 8(6). 1051–1058.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Mark G. Lewis Breakdown of academic impact, for papers by Preston A. Marx Breakdown of academic impact, for papers by Jan Albert Breakdown of academic impact, for papers by Feng Gao Breakdown of academic impact, for papers by Mark B. Feinberg Breakdown of academic impact, for papers by Mark J. Mulligan Breakdown of academic impact, for papers by Francis A. Plummer Breakdown of academic impact, for papers by Luc Perrin Breakdown of academic impact, for papers by Stuart C. Ray Breakdown of academic impact, for papers by Hanneke Schuitemaker